Use and effect of Vriddhadarvadya Lauha In Amavata Rheumatoid arthritis

Pharmaceutico analytical study and clinical efficacy of Vriddhadarvadya lauha in Amavata wsr to Rheumatoid Arthritis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/096773

Enrollment

Registered

2025-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Amavata signs and symptoms morning stiffness tenderness and swelling of joints ete Results of lab tests showing RA factor and CRP test Patients between the ages of 20 yrs to 70 yrs

Exclusion criteria

Exclusion criteria: Patients having severe deformity and complications patients suffering from serious illnesses like cancer chronic liver failure etc Pregnant and lactating women A patient with any drug sensitivity Patients age below 20 yrs and above 70 yrs

Design outcomes

Primary

Measure	Time frame
Change in RA factor and CRP readingTimepoint: 2 months	—

Secondary

Measure	Time frame
RA factor and CRP will be assessedTimepoint: 15 days,30 days & 45 days	—

Countries

India

Contacts

Public ContactDr Ajay Kumar Sharma

Madan Mohan Malviya Government Ayurved College Udaipur

sharmadrajay@yahoo.com9413257535

Outcome results